Immunology of asthma and chronic obstructive pulmonary disease

[1]  K. Nakanishi,et al.  IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. , 2010, The Journal of Immunology.

[2]  P. Barnes,et al.  Role of GATA-3 in allergic diseases. , 2008, Current molecular medicine.

[3]  W. Leonard,et al.  Interleukin-21: basic biology and implications for cancer and autoimmunity. , 2008, Annual review of immunology.

[4]  D. Umetsu,et al.  T cells and NKT cells in the pathogenesis of asthma. , 2008, Annual review of medicine.

[5]  P. Barnes,et al.  CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. , 2008, Chest.

[6]  W. Busse,et al.  A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. , 2007, American journal of respiratory and critical care medicine.

[7]  I. McInnes,et al.  IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.

[8]  K. Nakanishi,et al.  IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation1 , 2007, The Journal of Immunology.

[9]  I. Pavord,et al.  Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. , 2007, The Journal of allergy and clinical immunology.

[10]  P. Jeffery,et al.  Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study , 2007, Thorax.

[11]  I. Pavord,et al.  Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis , 2007, European Respiratory Journal.

[12]  M. Larché.  Regulatory T cells in allergy and asthma. , 2007, Chest.

[13]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[14]  N. Pearce,et al.  Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) , 2007, Thorax.

[15]  A. D. Panopoulos,et al.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.

[16]  Y. Wan,et al.  Regulatory T Cells, Transforming Growth Factor–β, and Immune Suppression , 2007 .

[17]  Dave Singh,et al.  CD4-regulatory cells in COPD patients. , 2007, Chest.

[18]  Brigitta Stockinger,et al.  Differentiation and function of Th17 T cells. , 2007, Current opinion in immunology.

[19]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[20]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[21]  P. Barnes.  Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic , 2007, PLoS medicine.

[22]  R. Djukanović,et al.  Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[23]  B. Chiang,et al.  The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma , 2007, Clinical and experimental immunology.

[24]  S. Ziegler,et al.  Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells , 2007, The Journal of experimental medicine.

[25]  Ian M. Adcock,et al.  Regulation of Th2 Cytokine Genes by p38 MAPK-Mediated Phosphorylation of GATA-31 , 2007, The Journal of Immunology.

[26]  S. Pai,et al.  GATA-3 - not just for Th2 cells anymore. , 2007, Cellular & molecular immunology.

[27]  P. Avila.  Does anti-IgE therapy help in asthma? Efficacy and controversies. , 2007, Annual review of medicine.

[28]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[29]  I. Finegold.  Allergen immunotherapy: present and future. , 2007, Allergy and asthma proceedings.

[30]  Stephen R Durham,et al.  Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. , 2007, The Journal of allergy and clinical immunology.

[31]  W. Busse,et al.  Severe asthma: lessons from the Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[32]  P. Hellings,et al.  IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? , 2006, Respiratory research.

[33]  I. Douglas,et al.  Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? , 2006, Proceedings of the American Thoracic Society.

[34]  R. Sabat,et al.  Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. , 2006, Cytokine & growth factor reviews.

[35]  P. Barnes,et al.  Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. , 2006, Trends in pharmacological sciences.

[36]  P. Gibson,et al.  Asthma exacerbations · 3: Pathogenesis , 2006, Thorax.

[37]  W. Arap,et al.  State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. , 2006, Proceedings of the American Thoracic Society.

[38]  S. Wenzel.  Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[39]  H. Hammad,et al.  Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. , 2006, The Journal of allergy and clinical immunology.

[40]  P. Barnes.  Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. , 2006, American journal of respiratory and critical care medicine.

[41]  M. Kraft,et al.  Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! , 2006, American journal of respiratory and critical care medicine.

[42]  P. Barnes,et al.  Transcription factors in airway diseases , 2006, Laboratory Investigation.

[43]  I. Adcock,et al.  Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. , 2006, American journal of respiratory and critical care medicine.

[44]  P. Barnes.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005 , 2006, British journal of pharmacology.

[45]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[46]  I. Adcock,et al.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[47]  J. Edwards,et al.  B-cell targeting in rheumatoid arthritis and other autoimmune diseases , 2006, Nature Reviews Immunology.

[48]  L. Fabbri,et al.  Pathophysiology of exacerbations of chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[49]  Yuka Kanno,et al.  T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription , 2006, The Journal of experimental medicine.

[50]  G. Berry,et al.  CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.

[51]  I. Rahman,et al.  Oxidant and antioxidant balance in the airways and airway diseases. , 2006, European journal of pharmacology.

[52]  N. Lukacs,et al.  A closer look at chemokines and their role in asthmatic responses. , 2006, European journal of pharmacology.

[53]  L. Reber,et al.  Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. , 2006, European journal of pharmacology.

[54]  K. Kurashima,et al.  Asthma severity is associated with an increase in both blood CXCR3+ and CCR4+ T cells , 2006, Respirology.

[55]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin: master switch for allergic inflammation , 2006, The Journal of experimental medicine.

[56]  A. B. Kay,et al.  The role of T lymphocytes in asthma. , 2006, Chemical immunology and allergy.

[57]  P. Barnes.  Reduced histone deacetylase in COPD: clinical implications. , 2006, Chest.

[58]  P. Sterk,et al.  Bronchial CD8 cell infiltrate and lung function decline in asthma. , 2005, American journal of respiratory and critical care medicine.

[59]  John D. Mitchell,et al.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. , 2005, American journal of respiratory and critical care medicine.

[60]  D. Robinson,et al.  Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1 , 2005, The Journal of Immunology.

[61]  S. Kunkel,et al.  Chemokines and their receptors in chronic pulmonary disease. , 2005, Current drug targets. Inflammation and allergy.

[62]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[63]  H. H. Choo,et al.  Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. , 2005, American journal of respiratory and critical care medicine.

[64]  I. Pavord,et al.  Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease , 2005, Thorax.

[65]  S. Johnston,et al.  Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. , 2005, American journal of respiratory and critical care medicine.

[66]  Pamela L. Schwartzberg,et al.  T Helper Cell Fate Specified by Kinase-Mediated Interaction of T-bet with GATA-3 , 2005, Science.

[67]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.

[68]  P. Barnes.  Mediators of Chronic Obstructive Pulmonary Disease , 2004, Pharmacological Reviews.

[69]  I. Adcock,et al.  Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease , 2004, Histopathology.

[70]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[71]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[72]  P. Barnes,et al.  Prospects for new drugs for chronic obstructive pulmonary disease , 2004, The Lancet.

[73]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[74]  P. Barnes,et al.  Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2 , 2004, Journal of leukocyte biology.

[75]  I. Adcock,et al.  Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. , 2004, American journal of respiratory and critical care medicine.

[76]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[77]  I. Adcock,et al.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase , 2004, The Lancet.

[78]  M. Dallman,et al.  Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease , 2004, The Lancet.

[79]  P. Barnes.  Alveolar Macrophages as Orchestrators of COPD , 2004, COPD.

[80]  N. Siafakas,et al.  Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. , 2004, Chest.

[81]  M. Cosio,et al.  Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.

[82]  T. Williams,et al.  CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 , 2003, European journal of immunology.

[83]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[84]  L. Fabbri,et al.  Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. , 2003, Thorax.

[85]  P. Barnes.  Theophylline: new perspectives for an old drug. , 2003, American journal of respiratory and critical care medicine.

[86]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[87]  Anjana Rao,et al.  TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes , 2002, Nature Immunology.

[88]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[89]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[90]  P. Phelan,et al.  The Melbourne Asthma Study: 1964-1999. , 2002, The Journal of allergy and clinical immunology.

[91]  S. Szabo,et al.  Development of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-bet , 2002, Science.

[92]  P. Holt,et al.  Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge , 2001, Thorax.

[93]  I. Adcock,et al.  Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. , 2001, The European respiratory journal.

[94]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[95]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[96]  J. Kips,et al.  Cytokines in asthma , 2001, European Respiratory Journal.

[97]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[98]  M. Cosio,et al.  Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. , 2001, The European respiratory journal.

[99]  J. Lötvall,et al.  IL‐17‐induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen‐activated protein (MAP) kinases , 2001, British journal of pharmacology.

[100]  R. Wu,et al.  Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. , 2001, American journal of respiratory and critical care medicine.

[101]  P. Cullinan,et al.  Cyclosporin as an oral corticosteroid sparing agent in stable asthma. , 2000, The Cochrane database of systematic reviews.

[102]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[103]  L. Fabbri,et al.  Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[104]  P. Barnes,et al.  Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.

[105]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[106]  E. Tagaya,et al.  Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study , 2000, The Lancet.

[107]  P. Jeffery,et al.  Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.

[108]  P. Barnes,et al.  Mechanisms in COPD: differences from asthma. , 2000, Chest.

[109]  D. Vercelli,et al.  IgE isotype determination: epsilon-germline gene transcription, DNA recombination and B-cell differentiation. , 2000, British medical bulletin.

[110]  S. Durham,et al.  The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. , 1999, Immunology today.

[111]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[112]  P. Montuschi,et al.  Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. , 1999, American journal of respiratory and critical care medicine.

[113]  D. H. Zhang,et al.  Gene expression of the GATA-3 transcription factor is increased in atopic asthma. , 1999, The Journal of allergy and clinical immunology.

[114]  K. Chung,et al.  Inflammatory mediators of asthma: an update. , 1998, Pharmacological reviews.

[115]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[116]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[117]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[118]  L. Fabbri,et al.  Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitis , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[119]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[120]  R. Dworski,et al.  New therapies for asthma. , 1994, Comprehensive therapy.

[121]  P. Soler,et al.  Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. , 1989, The American review of respiratory disease.

[122]  L. Staiano‐Coico,et al.  Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. , 1988, Journal of immunology.

[123]  C. G. Becker,et al.  Effects of tobacco glycoprotein (TGP) on the immune system. III. The effect of aging on the mitogenic response of human peripheral blood lymphocytes to TGP. , 1987, Cellular immunology.